Álvaro
López Janeiro
Colaborador Clínico
University of Toronto
Toronto, CanadáPublications in collaboration with researchers from University of Toronto (1)
2023
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378